A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2011
06/23/2011	US20110152352 Smad proteins control drosha-mediated mirna maturation
06/23/2011	US20110152351 Modulation of smrt expression
06/23/2011	US20110152350 Compositions and Methods for Inhibiting Expression of XBP-1 Gene
06/23/2011	US20110152349 Compositions and methods for inhibiting expression of il-18 genes
06/23/2011	US20110152348 Methods for treating androgen receptor dependent disorders including cancers
06/23/2011	US20110152347 Methods and compositions for controlling efficacy of RNA silencing
06/23/2011	US20110152346 Use of Oligonucleotides with Modified Bases in Hybridization of Nucleic Acids
06/23/2011	US20110152345 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
06/23/2011	US20110152344 Inhibition of filovirus entry into cells and uses thereof
06/23/2011	US20110152343 Protease inhibitors and broad-spectrum antiviral
06/23/2011	US20110152342 Stabilized pharmaceutical composition
06/23/2011	US20110152341 Cleavage of b-amyloid precursor protein
06/23/2011	US20110152340 Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors
06/23/2011	US20110152339 Fluorescent regulators of rassf1a expression and human cancer cell proliferation
06/23/2011	US20110152338 Cycloalkane[b]indole antagonists of prostaglandin d2 receptors
06/23/2011	US20110152337 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2011	US20110152336 Combination therapy with parp inhibitors
06/23/2011	US20110152335 Allantoin-containing skin cream
06/23/2011	US20110152334 Mglu2 agonists
06/23/2011	US20110152333 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
06/23/2011	US20110152332 Pesticidal Heterocyclic Compounds
06/23/2011	US20110152331 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
06/23/2011	US20110152330 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
06/23/2011	US20110152329 Use of Epothilone Derivatives for the Treatment of Hyperparathyroidism
06/23/2011	US20110152328 Combination Therapy For Glaucoma
06/23/2011	US20110152327 Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
06/23/2011	US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists
06/23/2011	US20110152325 Carboxamide compounds and their use as calpain inhibitors iv
06/23/2011	US20110152324 Therapeutic agents useful for treating pain
06/23/2011	US20110152323 Histone deacetylase inhibitors and uses thereof
06/23/2011	US20110152321 Bicyclic derivatives useful as inhibitors of dpp-1
06/23/2011	US20110152320 Pyrrole derivatives, their preparation and their therapeutic application
06/23/2011	US20110152319 Method to predict response to pharmacological chaperone treatment of diseases
06/23/2011	US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
06/23/2011	US20110152317 Prevennting the occurrence of obesity
06/23/2011	US20110152316 3,4-substituted piperidine derivatives as renin inhibitors
06/23/2011	US20110152315 Compounds for the treatment of metabolic diseases
06/23/2011	US20110152314 Use of tenatoprazole for the treatment of gastroesophageal reflux disease
06/23/2011	US20110152313 Synthesis of ageladine a and analogs thereof
06/23/2011	US20110152312 Antiparisitic dihydroazole compounds and compositions comprising same
06/23/2011	US20110152311 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
06/23/2011	US20110152310 Tricyclic triazole compounds that modulate hsp90 activity
06/23/2011	US20110152309 Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter
06/23/2011	US20110152308 Aza-ring fused indole and indoline derivatives
06/23/2011	US20110152307 Ophthalmic composition comprising ascomycin
06/23/2011	US20110152306 Aza-bridged ring-fused indoles and indolines
06/23/2011	US20110152305 Films and particles
06/23/2011	US20110152304 Spiroazaindoles
06/23/2011	US20110152303 Chemical Compounds
06/23/2011	US20110152302 Novel dicyclanil-based shelf stable aqueous suspension and non-aqueous solution pour-on and spray-on formulations useful for the prevention and treatment of insect infestation in animals
06/23/2011	US20110152301 Compounds that Inhibit HIV Particle Formation
06/23/2011	US20110152299 Substituted benzamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
06/23/2011	US20110152298 Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
06/23/2011	US20110152297 Quinazoline derivatives as tyrosine kinase inhibitors
06/23/2011	US20110152296 Heterocyclic compounds and their uses
06/23/2011	US20110152295 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/23/2011	US20110152294 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising osmolyte as active agent component
06/23/2011	US20110152293 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
06/23/2011	US20110152292 Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use
06/23/2011	US20110152291 Novel aromatic compounds and their use in medical applications
06/23/2011	US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
06/23/2011	US20110152289 Dimeric derivatives of artemisinin and application in anti-cancer therapy
06/23/2011	US20110152288 Methods of treating vasomotor symptoms
06/23/2011	US20110152287 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1
06/23/2011	US20110152286 Piperazine-substituted benzothiophenes for treatment of mental disorders
06/23/2011	US20110152285 Pyrrole antifungal agents
06/23/2011	US20110152284 Sigma ligands for neuronal regeneration and functional recovery
06/23/2011	US20110152283 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
06/23/2011	US20110152282 Hedgehog pathway modulators
06/23/2011	US20110152281 Compounds and method for treatment of cancer
06/23/2011	US20110152280 Novel ergoline analogs
06/23/2011	US20110152279 Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
06/23/2011	US20110152278 Synthesis and anti-proliferative effect of benzimidazole derivatives
06/23/2011	US20110152277 Heterocyclic compounds and their uses
06/23/2011	US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates
06/23/2011	US20110152275 Agent for maintenance of induced remission
06/23/2011	US20110152274 Preparations and Methods for Ameliorating or Reducing Presbyopia
06/23/2011	US20110152273 Fused heteroaromatic pyrrolidinones
06/23/2011	US20110152272 Treatment Of Incontinence
06/23/2011	US20110152271 Compositions and methods for ophthalmic delivery of nasal decongestants
06/23/2011	US20110152270 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
06/23/2011	US20110152268 Novel pharmaceutical composition for treating nociceptive pain
06/23/2011	US20110152267 Compositions and Methods for Treating Hyperproliferative Disorders
06/23/2011	US20110152266 Co-crystal compound of rivaroxaban and malonic acid
06/23/2011	US20110152265 Carboxamide compounds and their use as calpain inhibitors v
06/23/2011	US20110152264 Method and composition for treating ocular hypertension and glaucoma
06/23/2011	US20110152263 Composition and method for inhibiting norovirus infection
06/23/2011	US20110152262 Novel compounds
06/23/2011	US20110152261 Organic compounds
06/23/2011	US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase
06/23/2011	US20110152259 Nitrogen-containing heterocyclic compounds and methods of use thereof
06/23/2011	US20110152258 Compounds and Methods for Kinase Modulation, and Indications Therefor
06/23/2011	US20110152257 Ethynyl compounds useful for treatment of cns disorders
06/23/2011	US20110152256 1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE AND PYRAZOLO[4,3-e]-1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
06/23/2011	US20110152255 Therapeutic compounds
06/23/2011	US20110152254 Sirtuin modulating compounds
06/23/2011	US20110152253 Spiroaminodihydrothiazine derivatives
06/23/2011	US20110152252 Shiga toxin b-subunit/chemotherapeutics conjugates
06/23/2011	US20110152251 Compounds for modulating tlr2
06/23/2011	US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof

1 ... 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 ... 7860